Clinical trial
Dopaminergic Dysfunction in Late-Life Depression
NCT04469959
Study timeline
Study start (actual)2021-02-15Date precision: day
Registry last updated2026-08-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Late Life Depressionunresolved
Cognitive Declineunresolved
Depressive Disorder, Treatment-Resistantunresolved
Levodopaunresolved
Gait Impairmentunresolved
Interventions
Sponsors & collaborators
Vanderbilt University Medical Centerlead sponsor
Emory Universitycollaborator
University of Pittsburghcollaborator
University of Pittsburgh Medical Centercollaborator
Rutgers Universitycollaborator
University of North Carolina, Chapel Hillcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04469959 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.